SCHEMBL29856149

SCHEMBL29856149

CC(C)c1c(C=O)c2ccncc2n1C

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ERN1 O75460 1/20 0.39
ROCK2 O75116 2/20 0.37
ADORA3 P0DMS8 2/20 0.37
ADORA2A P29274 2/20 0.37
DYRK1A Q13627 3/20 0.36
NFATC1 O95644 2/20 0.36
GSK3B P49841 2/20 0.36
AAK1 Q2M2I8 3/20 0.35
ALDH1A1 P00352 1/20 0.35
LMNA P02545 1/20 0.35
KCNH2 Q12809 1/20 0.34
CYP2A6 P11509 2/20 0.33
CYP1A2 P05177 2/20 0.33
POLB P06746 2/20 0.33
CYP2C19 P33261 2/20 0.33
ADORA1 P30542 1/20 0.31
HTT P42858 3/20 0.31
MAPT P10636 2/20 0.31
KDM5A P29375 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29955564 0.78 ERN1 (0.41) ERN1ROCK2ADORA3ADORA2ADYRK1A
SCHEMBL25899284 0.76 ADORA3 (0.39) ROCK2ADORA3ADORA2ADYRK1ANFATC1
SCHEMBL29856233 0.76 ERN1 (0.39) ERN1ROCK2ADORA3ADORA2ADYRK1A
SCHEMBL6487514 0.74 ALDH1A1 (0.68) ERN1ROCK2DYRK1ANFATC1GSK3B
SCHEMBL1609661 0.70 ADORA3 (0.54) ROCK2ADORA3ADORA2ADYRK1ANFATC1
SCHEMBL29856230 0.70 ROCK2 (0.42) ROCK2ADORA3ADORA2ALMNAHTT
SCHEMBL22346601 0.69 KDM4E (0.53) ADORA3ADORA2AALDH1A1LMNAPOLB
SCHEMBL25617163 0.68 TOP2A (0.37) ADORA3ADORA2ADYRK1ANFATC1GSK3B
SCHEMBL29856212 0.66 ADORA3 (0.40) ROCK2ADORA3ADORA2AALDH1A1LMNA
SCHEMBL14621514 0.66 LMNA (0.54) ALDH1A1LMNACYP1A2POLBCYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022169974-A1 INHIBITORS OF URAT1 AND PHARMACEUTICAL USES THEREOF NEXYS THERAPEUTICS, INC. (US) 2022-08-11 WO disclosed